ロード中...
AGR2 Predicts Tamoxifen Resistance in Postmenopausal Breast Cancer Patients
Endocrine resistance is a significant problem in breast cancer treatment. Thus identification and validation of novel resistance determinants is important to improve treatment efficacy and patient outcome. In our work, AGR2 expression was determined by qRT-PCR in Tru-Cut needle biopsies from tamoxif...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi Publishing Corporation
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3776368/ https://ncbi.nlm.nih.gov/pubmed/24167368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/761537 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|